1-8 of 8
Jose M. Polo, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCL6 Transcriptionally Reprograms the DLBCL Genome by Forming Distinct Biochemically Active Complexes on Genes Corresponding to Different Pathways.

Jose M. Polo, MS, Katerina Chatzi, PhD, Tania Dell’Oso, PhD, Paola Lev, PhD, Ari Melnick, PhD
Journal: Blood
Blood (2007) 110 (11): 2646.
https://doi.org/10.1182/blood.V110.11.2646.2646
Published: 2007
Journal Articles

Design and Development of Small Molecules for Specific Targeted Therapy of Diffuse Large B-Cell Lymphoma.

Gustavo F. Da Silva, MS, Alex Ghetu, PhD, Leandro Cerchietti, MD, Jose M. Polo, MS, Andrew Coop, PhD, Alexander Mackerell, PhD, Gilbert G. Prive, PhD, Ari Melnick, MD
Journal: Blood
Blood (2007) 110 (11): 799.
https://doi.org/10.1182/blood.V110.11.799.799
Published: 2007
Journal Articles

A Critical BCL6-Related Feedback Loop Explains the Unusual Biological Features of Germinal Center B-Cells and Their Malignant Transformation into B-Cell Lymphomas.

Stella M. Ranuncolo, MD, PhD, Jose M. Polo, MS, Jamil Dierov, PhD, Martin Carroll, MD, Ari M. Melnick, MD
Journal: Blood
Blood (2006) 108 (11): 224.
https://doi.org/10.1182/blood.V108.11.224.224
Published: 2006
Journal Articles

A BCL6 Target Gene Signature Predicts the Biological Behavior and Classification of Diffuse Large B-Cell Lymphoma.

Jose M. Polo, MS, Przemyslaw Juszczynski, MD, PhD, Leandro Cerchietti, MD, Stefano Monti, MD, Kenny Ye, PhD, Margaret A. Shipp, MD, Ari M. Melnick, MD
Journal: Blood
Blood (2006) 108 (11): 616.
https://doi.org/10.1182/blood.V108.11.616.616
Published: 2006
Journal Articles

The BCL6 Oncoprotein Forms Distinct Transcriptional Repression Complexes on Cohorts of Target Genes Involved in Specific Cellular Functions.

Jose M. Polo, MS, Stella Maris Ranuncolo, MD/PhD, Samir Parek, MD, Jose Arcaya, Ari M. Melnick, MD
Journal: Blood
Blood (2005) 106 (11): 2615.
https://doi.org/10.1182/blood.V106.11.2615.2615
Published: 2005
Journal Articles

BCL6, p53 and Molecular Targeted Therapy in B-Cell Lymphomas.

Leandro C.A. Cerchietti, MD, Jose M. Polo, MS, Gustavo F. Da Silva, Pharm D, Steve M. Dowdy, PhD, Catoretti M. Giorgio, MD, Shaknovich M. Rita, MD, Ari M. Melnick, MD
Journal: Blood
Blood (2005) 106 (11): 1484.
https://doi.org/10.1182/blood.V106.11.1484.1484
Published: 2005
Journal Articles

BCL6 Attenuates DNA Damage Sensing in Normal and Malignant B-Cells by Directly Repressing ATR.

Stella M. Ranuncolo, MD, PhD, Jose M. Polo, MS, Jamil Dierov, PhD, Rita Shaknovich, MD, Martin Carroll, MD, Ari M. Melnick, MD
Journal: Blood
Blood (2005) 106 (11): 157.
https://doi.org/10.1182/blood.V106.11.157.157
Published: 2005
Journal Articles

Specific Peptide Disruption of the Bcl-6 Repression Complex Reveals Its Transcriptional Mechanism of Action in Normal and Malignant B-Cells and Is a Novel Therapeutic Approach for Diffuse Large B-Cell Lymphoma.

Jose M. Polo, MS, Tania Dell’Oso, PhD, Stella Maris Ranuncolo, MD, PhD, Leandro Cerchietti, MD, Gustavo F. Da Silva, Pharm.D, Gilvert G. Prive, PhD, Jonathan D. Licht, MD, Ari Melnick, MD
Journal: Blood
Blood (2004) 104 (11): 5.
https://doi.org/10.1182/blood.V104.11.5.5
Published: 2004